Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
16.7%
% of IHE's 37 holdings also in MEDX
20.0%
% of MEDX's 30 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 25.8% | 18.6% | 18.6% |
|
JOHNSON & JOHNSON | 24.4% | 5.3% | 5.3% |
|
BRISTOL-MYERS SQUIBB CO | 4.1% | 5.8% | 4.1% |
|
PFIZER INC | 4.3% | 3.8% | 3.8% |
|
MERCK & CO. INC. | 4.2% | 3.5% | 3.5% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to MEDX
|
JOHNSON & JOHNSON | 19.1% |
|
ELI LILLY & CO | 7.1% |
|
ROYALTY PHARMA PLC CLASS A | 5.0% |
|
ZOETIS INC | 4.6% |
|
VIATRIS, INC. | 3.9% |
 |
JAZZ PHARMACEUTICALS PLC | 2.9% |
|
CORCEPT THERAPEUTICS INC | 2.7% |
|
AXSOME THERAPEUTICS, INC. | 2.0% |
|
ELANCO ANIMAL HEALTH, INC. | 1.9% |
|
PRESTIGE BRANDS HOLDINGS INC | 1.8% |
IHE Underweight Relative to MEDX
|
ABBVIE INC | -8.8% |
 |
NOVARTIS AG-ADR | -7.0% |
|
AMGEN INC | -6.2% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.6% |
|
ALNYLAM PHARMACEUTICALS INC | -4.5% |
|
ALKERMES PLC | -4.1% |
|
REGENERON PHARMACEUTICALS | -2.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -2.7% |
|
CRISPR THERAPEUTICS AG | -2.6% |
|
BIOGEN IDEC INC | -2.4% |